What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?
Anna M. Sawka(University of Toronto), Charlie H. Goldsmith(St. Joseph’s Healthcare Hamilton), Robert G. Josse(Western University), Jacques P. Brown(Centre hospitalier de l'Université Laval), David A. Hanley(The University of Sydney), George Ioannidis(McMaster University Medical Centre), Αλεξάνδρα Παπαϊωάννου(Western University), Jonathan D. Adachi(St. Peter's Hospital), Alan Tenenhouse(St. Vincent's Birmingham), Tim Murray, Rolf J. Sebaldt(Murdoch Children's Research Institute), Annie Petrie(McMaster University), Wojciech P. Olszynski(University of Saskatchewan)
Cited by 19
Related Papers
Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k